{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T03:45:09Z","timestamp":1790912709213,"version":"4.1.0"},"reference-count":57,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2021,7,30]],"date-time":"2021-07-30T00:00:00Z","timestamp":1627603200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nutrients"],"abstract":"<jats:p>The COVID-19 pandemic is the most challenging global health crisis of our times. Vaccination against COVID-19 plays a key role to control the current pandemic situation. The risk of allergic reactions to new COVID-19 vaccines is low. However, there is a debate on the safety in allergic patients following post marketing findings by different agencies. Our aim is to understand from current experiences whether children with cow\u2019s milk or food allergy are at higher risk than a general population for allergic reactions to COVID-19 vaccines. Current data indicate that patients with a history of allergy to cow\u2019s milk or other foods, even if severe, should receive COVID-19 vaccine in a setting with availability of treatments for anaphylactic reactions and under medical supervision. Recipients should be discharged after a protracted observation period of 30 min if no reaction developed.<\/jats:p>","DOI":"10.3390\/nu13082637","type":"journal-article","created":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T21:44:32Z","timestamp":1627854272000},"page":"2637","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["COVID-19 Vaccines in Children with Cow\u2019s Milk and Food Allergies"],"prefix":"10.3390","volume":"13","author":[{"given":"Lucia","family":"Liotti","sequence":"first","affiliation":[{"name":"Department of Pediatrics, AOU Ospedali Riuniti Ancona, Presidio Ospedaliero di Alta Specializzazione \u201cG. Salesi\u201d, 60100 Ancona, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annamaria","family":"Bianchi","sequence":"additional","affiliation":[{"name":"UOC Pediatria, Azienda Ospedaliera Ospedale San Camillo Forlanini, 00152 Roma, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Bottau","sequence":"additional","affiliation":[{"name":"Pediatric and Neonatology Unit, Imola Hospital, 40026 Imola, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Caimmi","sequence":"additional","affiliation":[{"name":"Dipartimento di Pediatria, Fondazione IRCCS Policlinico San Matteo, Universit\u00e0 di Pavia, 27100 Pavia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Crisafulli","sequence":"additional","affiliation":[{"name":"UOC Allergologia, Dipartimento Materno-Infantile, Universit\u00e0 di Messina, 98124 Messina, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrizio","family":"Franceschini","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, AOU Ospedali Riuniti Ancona, Presidio Ospedaliero di Alta Specializzazione \u201cG. Salesi\u201d, 60100 Ancona, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Mori","sequence":"additional","affiliation":[{"name":"Allergy Unit, Department of Pediatrics, Meyer Children\u2019s University Hospital, 50134 Florence, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Paglialunga","sequence":"additional","affiliation":[{"name":"Pediatric Department, Azienda Ospedaliera-Universitaria \u201cConsorziale-Policlinico\u201d, Ospedale Pediatrico Giovanni XXIII, 70126 Bari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9443-5483","authenticated-orcid":false,"given":"Francesca","family":"Saretta","sequence":"additional","affiliation":[{"name":"SC Pediatria, Ospedale Latisana-Palmanova, Dipartimento Materno-Infantile Azienda Sanitaria Universitaria Friuli Centrale, 33100 Udine, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7710-6995","authenticated-orcid":false,"given":"Carlo","family":"Caffarelli","sequence":"additional","affiliation":[{"name":"Clinica Pediatrica, Dipartimento di Medicina e Chirurgia, Universit\u00e0 di Parma, 43126 Parma, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,7,30]]},"reference":[{"key":"ref_1","unstructured":"(2021, May 15). American Academy of Pediatric Children and COVID-19: State-Level Data Report. Available online: https:\/\/services.aap.org\/en\/pages\/2019-novel-coronavirus-covid-19-infections\/children-and-covid-19-state-level-data-report\/."},{"key":"ref_2","unstructured":"Istituto Superiore Sanit\u00e0 (2021, May 15). Epidemia COVID-19 Aggiornamento nazionale 5 maggio 2021\u2014ore 12:00. Available online: https:\/\/www.epicentro.iss.it\/coronavirus\/sars-cov-2-sorveglianza-dati."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1186\/s13052-020-00928-y","article-title":"Health-care organization for the management and surveillance of SARS-CoV-2 infection in children during pandemic in Campania region, Italy","volume":"46","author":"Nunziata","year":"2020","journal-title":"Ital. J. Pediatr."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1002\/jmv.26398","article-title":"A systematic review and meta-analysis of children with coronavirus disease 2019 (COVID-19)","volume":"93","author":"Cui","year":"2021","journal-title":"J. Med. Virol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s00296-020-04749-4","article-title":"Severe COVID-19, multisystem inflammatory syndrome in children, and Kawasaki disease: Immunological mechanisms, clinical manifestations and management","volume":"41","author":"Kabeerdoss","year":"2021","journal-title":"Rheumatol. Int."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1056\/NEJMoa2021680","article-title":"Multisystem inflammatory syndrome in US Children and adolescents","volume":"383","author":"Feldstein","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1016\/S0140-6736(20)31094-1","article-title":"Hyperinflammatory shock in children during COVID-19 pandemic","volume":"395","author":"Riphagen","year":"2020","journal-title":"Lancet"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1007\/s00431-020-03801-6","article-title":"COVID-19 Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in children and adolescents: A systematic review of critically unwell children and the association with underlying comorbidities","volume":"180","author":"Williams","year":"2021","journal-title":"Eur. J. Pediatr."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/S2352-4642(20)30177-2","article-title":"COVID-19 in children and adolescents in Europe: A multinational, multicentre cohort study","volume":"4","author":"Lanaspa","year":"2020","journal-title":"Lancet Child Adolesc. Health"},{"key":"ref_10","unstructured":"NICE Guideline (2021, July 11). COVID-19 Rapid Guideline: Managing COVID-19. 3 June 2021. Available online: https:\/\/www.nice.org.uk\/guidance\/ng191."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/s13052-020-00843-2","article-title":"Consensus statement of the Italian society of pediatric allergy and immunology for the pragmatic management of children and adolescents with allergic or immunological diseases during the COVID-19 pandemic","volume":"46","author":"Cardinale","year":"2020","journal-title":"Ital. J. Pediatr."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1111\/pai.12625","article-title":"Skin prick test and development of tolerance in egg allergy","volume":"27","author":"Caffarelli","year":"2016","journal-title":"Pediatr. Allergy Immunol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.anai.2020.09.003","article-title":"Trends in US hospitalizations for anaphylaxis among infants and toddlers: 2006 to 2015","volume":"126","author":"Robinson","year":"2021","journal-title":"Ann. Allergy Asthma Immunol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"177","DOI":"10.2500\/aap.2018.39.4128","article-title":"Evaluating children with suspected allergic reactions to vaccines for infectious diseases","volume":"39","author":"Franceschini","year":"2018","journal-title":"Allergy Asthma Proc."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1111\/pai.12762","article-title":"Vaccination and allergy: EAACI position paper, practical aspects","volume":"28","author":"Nilsson","year":"2017","journal-title":"Pediatr. Allergy Immunol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.jaci.2017.12.971","article-title":"Vaccine-associated hypersensitivity","volume":"141","author":"McNeil","year":"2018","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s40413-016-0120-5","article-title":"International Consensus (ICON): Allergic reactions to vaccines","volume":"9","author":"Dreskin","year":"2016","journal-title":"World Allergy Organ. J."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1016\/j.jaci.2018.12.1003","article-title":"Anaphylaxis after vaccination reported to the Vaccine Adverse Event Reporting System, 1990-2016","volume":"143","author":"Su","year":"2019","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/j.jaci.2015.07.048","article-title":"Risk of anaphylaxis after vaccination in children and adults","volume":"137","author":"McNeil","year":"2016","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_20","unstructured":"Institute for Vaccine Safety Johns Hopkins Bloomberg School of Public Health (2021, July 11). Potential Allergen in Vaccines per 0.5 mL Dose. Available online: http:\/\/vaccinesafety.edu\/components-Allergens.htm."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1080\/1744666X.2020.1814745","article-title":"Diagnosis and management of hypersensitivity reactions to vaccines","volume":"16","author":"Sarti","year":"2020","journal-title":"Expert Rev. Clin. Immunol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.vaccine.2020.12.084","article-title":"Anaphylactic reactions to novel mRNA SARS-CoV-2\/COVID-19 vaccines","volume":"39","author":"Kelso","year":"2021","journal-title":"Vaccine"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","article-title":"Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine","volume":"383","author":"Polack","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_24","unstructured":"U.S. Food and Drug Administration (2021, May 15). Pfizer-BioNTech COVID-19 Vaccine (BNT162, PF-07302048) [FDA Briefing Document], Available online: https:\/\/www.fda.gov\/media\/144246\/download."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Centers for Disease Control and Prevention COVID-19 Response Team, and Food and Drug Administration (2021). Allergic reactions including anaphylaxis after receipt of the first dose of Moderna COVID-19 vaccine\u2014United States, December 21, 2020\u2013January 10, 2021. MMWR Morb. Mortal. Wkly. Rep., 70, 125\u2013129.","DOI":"10.15585\/mmwr.mm7004e1"},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Centers for Disease Control and Prevention COVID-19 Response Team (2021). Allergic Reactions Including Anaphylaxis after Receipt of the First Dose of Pfizer-BioNTech COVID-19 Vaccine-United States, December 14\u201323, 2020. MMWR Morb. Mortal. Wkly Rep., 70, 46\u201351.","DOI":"10.15585\/mmwr.mm7002e1"},{"key":"ref_27","unstructured":"Raine, J. (2021, May 15). Confirmation of guidance to vaccination centres on managing allergic reactions following COVID-19 vaccination with the Pfizer\/BioNTech Vaccine. Press Release. Medicines and Healthcare Products Regulatory Agency (MHRA), Available online: https:\/\/www.gov.uk\/government\/news\/confirmation-of-guidance-to-vaccination-centres-on-managing-allergic-reactions-following-covid-19-vaccination-with-the-pfizer-biontech-vaccine."},{"key":"ref_28","unstructured":"Medicines and Healthcare Products Regulatory Agency (MHRA) (2021, May 15). Oxford University\/AstraZeneca COVID-19 Vaccine Approved, Available online: https:\/\/www.gov.uk\/government\/news\/oxford-universityastrazeneca-covid-19-vaccine-approved."},{"key":"ref_29","unstructured":"Centers for Disease Control and Prevention (2021, May 15). Interim Clinical Considerations for Use of mRNA COVID-19 Vaccines Currently Authorized in the United States, Available online: www.cdc.gov\/vaccines\/covid-19\/info-by-product\/clinical-considerations.html."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"4398","DOI":"10.1016\/j.vaccine.2015.07.035","article-title":"Safety monitoring in the Vaccine Adverse Event Reporting System (VAERS)","volume":"33","author":"Shimabukuro","year":"2015","journal-title":"Vaccine"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"5675","DOI":"10.1016\/j.vaccine.2007.02.064","article-title":"Anaphylaxis: Case definition and guidelines for data collection, analysis, and presentation of immunization safety data","volume":"25","author":"Gold","year":"2007","journal-title":"Vaccine"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"4407","DOI":"10.1016\/j.vaccine.2021.06.058","article-title":"Relationship between pre-existing allergies and anaphylactic reactions post mRNA COVID-19 vaccine administration","volume":"39","author":"Desai","year":"2021","journal-title":"Vaccine"},{"key":"ref_33","unstructured":"(2021, May 15). Third AIFA Report on COVID-19 Vaccine Surveillance Report, Available online: www.aifa.gov.it\/farmacovigilanza-vaccini-covid-19."},{"key":"ref_34","unstructured":"Medicines and Healthcare Products Regulatory Agency (MHRA) (2021, May 15). Coronavirus Vaccine\u2014Weekly Summary of Yellow Card Reporting\u2014Updated 13 May 2021, Available online: https:\/\/www.gov.uk\/government\/publications\/coronavirus-covid-19-vaccine-adverse-reactions\/coronavirus-vaccine-summary-of-yellow-card-reporting."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1001\/jama.2021.3976","article-title":"Acute allergic reactions to mRNA COVID-19 vaccines","volume":"325","author":"Blumenthal","year":"2021","journal-title":"JAMA"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1016\/j.jaci.2021.04.002","article-title":"Potential mechanisms of anaphylaxis to COVID-19 mRNA vaccines","volume":"147","author":"Risma","year":"2021","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_37","unstructured":"Australian Government Department of Health (2021, July 11). Therapeutic Good Administration. Consumer. Medicine, Available online: https:\/\/www.tga.gov.au\/what-ingredients-are-my-medicine."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"100517","DOI":"10.1016\/j.waojou.2021.100517","article-title":"COVID-19 vaccine-associated anaphylaxis: A statement of the World Allergy Organization Anaphylaxis Committee","volume":"14","author":"Turner","year":"2021","journal-title":"World Allergy Organ. J."},{"key":"ref_39","unstructured":"(2021, May 15). Covid-19 Vaccine Janssen EPAR-Risk Management Plan. Available online: https:\/\/www.ema.europa.eu\/documents\/rmp-summary\/covid-19-vaccine-janssen-epar-risk-management-plan_en.pdf."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1111\/all.14739","article-title":"EAACI statement on the diagnosis, management and prevention of severe allergic reactions to COVID-19 vaccines","volume":"76","author":"Sokolowska","year":"2021","journal-title":"Allergy"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/j.jaci.2014.10.021","article-title":"Increase in anaphylaxis-related hospitalizations but no increase in fatalities: An analysis of United Kingdom national anaphylaxis data, 1992-2012","volume":"135","author":"Turner","year":"2015","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"17098","DOI":"10.1038\/nrdp.2017.98","article-title":"Food allergy","volume":"4","author":"Renz","year":"2018","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/j.jaci.2010.10.011","article-title":"Diagnosis and Rationale for Action Against Cow\u2019s Milk Allergy (DRACMA): A summary report","volume":"126","author":"Fiocchi","year":"2010","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Knol, E.F., de Jong, N.W., Ulfman, L.H., and Tiemessen, M.M. (2019). Management of cow\u2019s milk allergy from an immunological perspective: What are the options?. Nutrients, 11.","DOI":"10.3390\/nu11112734"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.jaci.2011.04.036","article-title":"Dietary baked milk accelerates the resolution of cow\u2019s milk allergy in children","volume":"128","author":"Kim","year":"2011","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/pai.12659","article-title":"Non-IgE-mediated gastrointestinal food allergies in children","volume":"28","author":"Caubet","year":"2017","journal-title":"Pediatr. Allergy Immunol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/pai.12563","article-title":"EAACI Molecular Allergology User\u2019s Guide","volume":"27","author":"Matricardi","year":"2016","journal-title":"Pediatr. Allergy Immunol."},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Caglayan-Sozmen, S., Santoro, A., Cipriani, F., Mastrorilli, C., Ricci, G., and Caffarelli, C. (2019). Hazardous medications in children with egg, red meat, gelatin, fish, and cow\u2019s milk allergy. Medicina (Kaunas), 55.","DOI":"10.3390\/medicina55080501"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"180","DOI":"10.18176\/jiaci.0683","article-title":"Safety of new mRNA vaccines against COVID-19 in severely allergic patients","volume":"31","year":"2021","journal-title":"J. Investig. Allergol. Clin. Immunol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1016\/j.jaci.2020.01.017","article-title":"Anaphylaxis-a 2020 practice parameter update, systematic review, and Grading of Recommendations, Assessment, Development and Evaluation (GRADE) analysis","volume":"145","author":"Shaker","year":"2020","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Mastrorilli, C., Cardinale, F., Giannetti, A., and Caffarelli, C. (2019). Pollen-Food Allergy Syndrome: A not so rare disease in childhood. Medicina (Kaunas), 55.","DOI":"10.3390\/medicina55100641"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.jaip.2020.09.029","article-title":"Polyethylene glycol-induced systemic allergic reactions (anaphylaxis)","volume":"9","author":"Sellaturay","year":"2021","journal-title":"J. Allergy Clin. Immunol. Pract."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1016\/j.jaip.2020.11.011","article-title":"Anti-PEG IgE in anaphylaxis associated with polyethylene glycol","volume":"9","author":"Zhou","year":"2021","journal-title":"J. Allergy Clin. Immunol. Pract."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1016\/j.jaip.2020.12.047","article-title":"mRNA vaccines to prevent COVID-19 disease and reported allergic reactions: Current evidence and approach","volume":"9","author":"Banerji","year":"2021","journal-title":"J. Allergy Clin. Immunol. Pract."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1056\/NEJMc2102131","article-title":"Delayed large local reactions to mRNA-1273 vaccine against SARS-CoV-2","volume":"384","author":"Blumenthal","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1159\/000328760","article-title":"Definitions, criteria and global classification of mast cell disorders with special reference to mast cell activation syndromes: A consensus proposal","volume":"157","author":"Valent","year":"2012","journal-title":"Int. Arch. Allergy Immunol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.jaci.2021.01.004","article-title":"mRNA COVID-19 vaccine is well tolerated in patients with cutaneous and systemic mastocytosis with mast cell activation symptoms and anaphylaxis","volume":"147","author":"Rama","year":"2021","journal-title":"J. Allergy Clin. Immunol."}],"container-title":["Nutrients"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6643\/13\/8\/2637\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T06:37:11Z","timestamp":1760164631000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6643\/13\/8\/2637"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,30]]},"references-count":57,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2021,8]]}},"alternative-id":["nu13082637"],"URL":"https:\/\/doi.org\/10.3390\/nu13082637","relation":{},"ISSN":["2072-6643"],"issn-type":[{"value":"2072-6643","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,30]]}}}